Biotech Values

[DewDiligence]

MNTA Liquidity and Cash Usage

[Updated for3Q09 results.]


At the rate of operating cash burn during 3Q09, the 9/30/09 cash
balance of $107.3M is sufficient to cover operating expenses
for more than two years.

Operating cash burn and quarter-ending cash balance for
the past eight quarters were as follows (all figures in $M):

 
       Ending  Cash     
        Cash   Burn  iHub reference  
 3Q09  107.3*  11.6  #msg-43259757 
 2Q09   72.1   13.3‡ #msg-40259357 
 1Q09   87.9   20.6  #msg-37645888 
 4Q08  108.5†  11.0  #msg-35548032 
 3Q08   95.4   14.0  #msg-33301993 
 2Q08  109.4   14.2  #msg-30936204 
 1Q08  123.6   12.3  #msg-29095630 
 4Q07  135.9    n/a  #msg-26836951 
      
 *$46.8M raised in Sep 2009 financing. 
 ‡A $2.5M reimbursement from NVS booked in June and received  
 in early July is offset against 2Q09 rather than 3Q09 burn.   
 †$24.1M raised in Dec 2008 financing.